Lauxera Capital Partners

OrganOx is a medical device company focused on organ preservation and transplantation, specializing in normothermic preservation technology that mimics physiological conditions to protect livers before transplantation. The company develops and manufactures systems that continuously perfuse livers at body temperature with oxygenated blood, nutrients, and controlled pressures and flows to reduce decay, support bile production, glucose metabolism, and pH stability. Its Metra device stores livers outside the body at normal body temperature, enabling testing and transplantation. OrganOx was founded in 2008 and is based in Oxford, United Kingdom. The technology aims to improve transplant outcomes by maintaining organ viability during storage and enabling more flexible transplantation timelines.

Acandis GmbH is a manufacturer of medical devices focused on the treatment of neurovascular diseases. The company specializes in a range of products, including engineering stroke solutions, flow diverters, stent retrievers, embolization devices, acute stroke care solutions, thrombectomy tools, and percutaneous transluminal angioplasty (PTA) devices. Acandis aims to support neuroradiologists by providing innovative and user-oriented devices that address both technical and medical challenges. The company's commitment to understanding symptoms, diagnostics, and treatment options allows it to develop comprehensive solutions that enhance patient care in acute stroke scenarios.

Synovo Group specializes in digital services for medical transport professionals. They offer a range of solutions including hosting, infrastructure management, cloud services, telecom support, and security consultancy, ensuring compliance with health data standards.

Natural Cycles is a digital health company that provides a contraceptive app aimed at enhancing women's reproductive health. The app allows users to track their basal body temperature daily, using a specialized thermometer to input data. This information, combined with other relevant metrics, is analyzed through a proprietary algorithm to determine fertility status throughout the menstrual cycle. The app features a color-coded calendar that informs users about their fertile days, helping them decide when they can have unprotected sex. By offering a non-invasive, non-hormonal method of fertility tracking, Natural Cycles empowers women to take control of their reproductive health and make informed decisions about family planning.

BioLamina AB is a biotechnology company based in Sundbyberg, Sweden, founded in 2009. It specializes in the development, manufacture, marketing, and sale of laminin cell culture products that support advanced cell research. The company offers a range of defined human recombinant laminin matrices designed to facilitate the culture of stem cells and tissue-specific cells. These products are utilized in various applications, including human and mouse embryonic stem cell culturing, the creation of beta cell islets, and single cell culturing. By mimicking natural cell-specific matrix interactions, BioLamina's reagents enhance the functionality of primary cells and contribute to the development of clinically compliant cell therapies. The company has established a strategic collaboration with CEVEC Pharmaceuticals GmbH to further its research and product offerings.

OrganOx is a medical device company focused on organ preservation and transplantation, specializing in normothermic preservation technology that mimics physiological conditions to protect livers before transplantation. The company develops and manufactures systems that continuously perfuse livers at body temperature with oxygenated blood, nutrients, and controlled pressures and flows to reduce decay, support bile production, glucose metabolism, and pH stability. Its Metra device stores livers outside the body at normal body temperature, enabling testing and transplantation. OrganOx was founded in 2008 and is based in Oxford, United Kingdom. The technology aims to improve transplant outcomes by maintaining organ viability during storage and enabling more flexible transplantation timelines.

Matrix Requirements is a global software company specializing in quality management solutions for innovative medical device manufacturers. Its flagship products, MatrixALM and MatrixQMS, help streamline regulatory processes by integrating agile development with compliance, ensuring product quality throughout the lifecycle.

Veranex is a global service provider that specializes in the medical technology sector, offering comprehensive, technology-enabled solutions from concept to commercialization. The company focuses exclusively on various areas within medical technology, including medical devices, diagnostics, companion diagnostics, digital health, and drug delivery. Veranex provides a wide range of services, such as design and engineering, regulatory support, clinical trials, and market access, enabling clients to streamline their development processes. By addressing the entire clinical trial journey, Veranex helps clients accelerate their time to market, enhance market viability, manage development costs, and reduce associated risks.

Lifen, a 160-employee Paris-based startup, specializes in streamlining medical data communication. Founded in 2015, it has become France's leading MSSanté operator, serving over 600 healthcare establishments and facilitating monthly exchanges of 2 million medical documents among 240,000 doctors. Lifen's platform simplifies data sharing through secure email, reducing paper mail and automating communication mode identification. Recognized for its interoperability expertise, Lifen aims to develop a platform that eases integration and deployment of digital solutions in healthcare.

Groupe PSIH provides healthcare data hosting and management services for managing activities of hospitals.

Caresyntax Inc. is a Boston-based company that provides a digital surgery platform to enhance surgical performance in hospitals and ambulatory surgical centers. Founded in 1991, it leverages data from over 1,600 hospitals globally to deliver insights that improve patient outcomes and operational efficiency. The platform integrates various data sources, including video, audio, clinical, and operational data, enabling real-time analysis and decision-making during surgeries. Caresyntax offers solutions such as qvident, a performance management software, and PRIME365, a comprehensive integration platform that consolidates surgical data and content. With a focus on automating workflows and reducing surgical variability, Caresyntax supports over 4,000 operating rooms and has facilitated millions of surgical procedures worldwide. The company’s HIPAA-compliant software can be deployed on-premise, in the cloud, or in a hybrid format, making it adaptable to diverse healthcare environments.

LUMICKS develops innovative technologies for studying biology and cancer at single-molecule and single-cell levels. Its products include C-Trap Optical Tweezers, Fluorescence Microscopy, and z-Movi Cell Avidity Analyzer, enabling real-time analysis of complex biological processes and interactions.

Reapplix is a Danish medical technology company that develops autologous wound therapy and tissue regeneration solutions derived from the patient's blood. It identifies and isolates blood-derived proteins to accelerate healing of chronic wounds and markets a device capable of delivering autologous active cell therapy to treat diabetic foot ulcers, with the aim of improving healing outcomes and reducing treatment costs. Founded in 2008 and based in Birkerod, Denmark, the company focuses on enabling hospitals to provide biological wound treatment using the patient's own cells.